{"id":"W2148923175","doi":"10.1200/jco.2009.26.5520","title":"Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Glioma; Concomitant; Internal medicine; Nausea; Anaplastic astrocytoma; Dacarbazine; Oncology; Progression-free survival; Phases of clinical research; Vomiting; Tumor progression; Radiation therapy; Surgery; Chemotherapy; Gastroenterology; Cancer; Astrocytoma; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001393298,0.001613687,0.002981102,0.0002524865,0.0002936017,0.0006484641,0.001062306,0.001083415,0.001815138],"category_scores_gemma":[0.0006066412,0.0003356201,0.001055868,0.0003399683,0.0008253122,0.0004764058,0.0003285166,0.002436173,0.0006252534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005951881,"about_ca_system_score_gemma":0.0011882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006871076,"about_ca_topic_score_gemma":0.001264781,"domain_scores_codex":[0.9995944,0.0002049648,0.00001830553,0.00007967089,0.00003560507,0.00006698949],"domain_scores_gemma":[0.9993236,0.00006280572,0.0001596255,0.00008039107,0.00003585159,0.0003377178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8503318,0.03032317,0.009093724,0.0005419017,0.001475216,0.0002734897,0.0002412288,0.001550008,0.03953198,0.0001696431,0.003267995,0.06319985],"study_design_scores_gemma":[0.6564206,0.3241152,0.01328383,0.00002023403,0.0004154674,0.0002959127,0.00003318181,0.0009529285,0.002833165,0.000135305,0.001472565,0.00002167392],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967209,0.001087321,0.0002665046,0.0002023261,0.00004609469,0.0008169496,0.0003897681,0.00005759001,0.0004126646],"genre_scores_gemma":[0.9940347,0.0007402076,0.0009117711,0.0005078816,0.0001254738,0.001463321,0.001365813,0.00002045145,0.0008304903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002981102,"threshold_uncertainty_score":0.007368565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1162981086235023,"score_gpt":0.4910405256228433,"score_spread":0.3747424169993411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}